These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27412566)

  • 1. While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.
    Coffin P; Rich J; Dailey M; Stancliff S; Beletsky L
    Addiction; 2016 Oct; 111(10):1880-1. PubMed ID: 27412566
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.
    Doe-Simkins M; Banta-Green C; Davis CS; Green TC; Walley AY
    Addiction; 2016 Oct; 111(10):1879-80. PubMed ID: 27412451
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
    Strang J; McDonald R; Tas B; Day E
    Addiction; 2016 Apr; 111(4):574-82. PubMed ID: 26840916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letters to Addiction from Coffin et al. and Doe-Simpkins et al. re: 'For Debate' on clinical use of improvised nasal naloxone sprays: authors' response.
    Strang J; McDonald R
    Addiction; 2016 Oct; 111(10):1881-3. PubMed ID: 27412695
    [No Abstract]   [Full Text] [Related]  

  • 5. Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.
    Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O
    Drugs; 2019 Sep; 79(13):1395-1418. PubMed ID: 31352603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults.
    Dale O
    Expert Opin Drug Metab Toxicol; 2022 Mar; 18(3):203-217. PubMed ID: 35500297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in per-patient naloxone requirements in an opioid epidemic.
    Birmingham LE; Nielson JA
    Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal.
    Strang J; McDonald R; Alqurshi A; Royall P; Taylor D; Forbes B
    Drug Alcohol Depend; 2016 Jun; 163():16-23. PubMed ID: 26996745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
    Fairbairn N; Coffin PO; Walley AY
    Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heroin and pharmaceutical opioid overdose events: Emergency medical response characteristics.
    Banta-Green CJ; Coffin PO; Schoeppe JA; Merrill JO; Whiteside LK; Ebersol AK
    Drug Alcohol Depend; 2017 Sep; 178():1-6. PubMed ID: 28623805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
    Strang J
    Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and response to opioid overdose deaths-New Mexico, 2012.
    Levy B; Spelke B; Paulozzi LJ; Bell JM; Nolte KB; Lathrop S; Sugerman DE; Landen M
    Drug Alcohol Depend; 2016 Oct; 167():29-35. PubMed ID: 27507658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
    Mundin G; McDonald R; Smith K; Harris S; Strang J
    Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
    Parmar MK; Strang J; Choo L; Meade AM; Bird SM
    Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
    Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
    Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study.
    McDonald R; Lorch U; Woodward J; Bosse B; Dooner H; Mundin G; Smith K; Strang J
    Addiction; 2018 Mar; 113(3):484-493. PubMed ID: 29143400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.